Delfi
DELFI Diagnostics | Blood-Based Lung Cancer Screening for Health Systems
Baltimore, United States · Founded 2019 · $325.0M raised
- Headquarters
- Baltimore, Maryland
- Founded
- 2019
- Business Model
- B2B
- Website
- delfidiagnostics.com
- Total Funding
- $325.0M
- Last Round
- $225.0M Series BJul 2022
- Rounds
- 2
About
AI and Analytics
Summary
Delfi is a Biotech company based in Baltimore, United States, founded in 2019. It has raised $325.0M in total across 2 rounds, most recently a $225.0M Series B round in Jul 2022. Investors include DFJ Growth.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jul 2022
Sign up to see all 2 rounds
Series A through Series B — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Minneapolis-based clinical stage biotechnology company focused on the development of molecularly ...
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/delfi"><img src="https://indexed.vc/api/badge/company/delfi" alt="Delfi on Indexed.vc" width="260" height="76" /></a>